Where can Deflazacort be purchased?

Deflazacort is a new glucocorticoid drug that has attracted attention in the fields of chronic inflammatory diseases, immune diseases and muscular dystrophy due to its lower water and sodium retention and bone side effects. Specific indications include but are not limited to Duchenne muscular dystrophy (DMD), rheumatoid arthritis, systemic lupus erythematosus, allergic diseases and other chronic diseases requiring glucocorticoid treatment. Compared with traditional glucocorticoids, Deflazacort has certain advantages in reducing long-term complications, so it is favored in long-term treatment options.

In terms of purchasing channels,Deflazacort’s original drug has not yet been officially launched in mainland China, so domestic patients cannot obtain it through regular pharmacies or hospitals. In overseas markets, the common specification of the European version of Deflazacort's original drug is 6mg*100 tablets, and patients can purchase it through regular overseas pharmacies or international drug transfer channels. It should be noted that before purchasing, you need to confirm the legality and reliability of the source of the medicine to avoid health risks caused by counterfeit medicines.

In addition, generic drugs of Deflazacort are also sold in overseas markets Among them, the generic drugs produced in India have basically the same ingredients as the original drugs and are relatively cheap. Generic drugs can significantly reduce patients' financial burden while meeting clinical efficacy, and are a common option for overseas patients.

Whether they choose original drugs or generic drugs, patients should conduct a professional evaluation before using Deflazacort, including disease type, severity and past drug reactions, to determine the appropriate dose and course of treatment. At the same time, regular monitoring of blood pressure, blood sugar, bone density, liver and kidney function and other indicators should be combined to ensure the safety of treatment.

In short,Deflazacort has a wide range of indications, especially in chronic immune and muscular dystrophic diseases. Although it has not yet been launched in China, through formal overseas channels, patients can still obtain the drug and carry out standardized treatment under the guidance of doctors, providing effective guarantee for disease management.

Reference: https://www.drugs.com/mtm/deflazacort.html